Cargando…

Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial)

BACKGROUND: Although postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, has become a standard of care for gastric cancer in Japan, nonresponders may suffer from the cost and adverse reactions without clinical benefit. This multicenter exploratory phase II trial was conducted to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanigawa, Nobuhiko, Yamaue, Hiroki, Ohyama, Shigekazu, Sakuramoto, Shinichi, Inada, Takao, Kodera, Yasuhiro, Kitagawa, Yuko, Omura, Kenji, Terashima, Masanori, Sakata, Yuh, Nashimoto, Atsushi, Yamaguchi, Toshiharu, Chin, Keisho, Nomura, Eiji, Lee, San-Woong, Takeuchi, Masahiro, Fujii, Masashi, Nakajima, Toshifusa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824809/ https://www.ncbi.nlm.nih.gov/pubmed/26385385 http://dx.doi.org/10.1007/s10120-015-0506-z

Ejemplares similares

Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)
por: Kimura, Yutaka, et al.
Publicado: (2017)

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial
por: Yoshida, Kazuhiro, et al.
Publicado: (2019)

In vitro Chemosensitivity Test of Human Gastric Carcinomas Using Collagen Gel Matrix
por: Ohyama, Shigekazu, et al.
Publicado: (1991)

Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study
por: Kodera, Yasuhiro, et al.
Publicado: (2023)

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11
por: Satake, Hironaga, et al.
Publicado: (2018)

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11
por: Satake, Hironaga, et al.
Publicado: (2018)

(18)F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12)
por: Nakamura, Masato, et al.
Publicado: (2021)

A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials
por: Sebio, A., et al.
Publicado: (2016)

5422107 Trichoderma harzianum SK-55 fungus, fungicide containing it, and method of manufacture of the same and its use : Kubota Terumas Kawachinagano, Japan Assigned to Hokkaido Green Kosan Incorporated
Publicado: (1996)

Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11)
por: Sunakawa, Y., et al.
Publicado: (2022)

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08
por: Masuishi, Toshiki, et al.
Publicado: (2020)

Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.
por: Yamaue, H., et al.
Publicado: (1992)

Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16
por: Yasui, H., et al.
Publicado: (2023)

Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy (COSMOS-DP trial): study protocol for a randomised controlled trial
por: Yamada, Suguru, et al.
Publicado: (2018)

Kudo K, Kubota Y, Toki T, et al. Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report. Blood Adv. 2022;6(10):3162-3166.
Publicado: (2022)

PEDT-04 SIX CASES OF RETINOBLASTOMA WITH CNS INVOLVEMENT
por: Kiyotani, Chikako, et al.
Publicado: (2019)

OA04-04. Perceived parental willingness for their adolescents to participate in future HIV prevention trials: a survey conducted amongst adolescents in Soweto
por: Otwombe, K, et al.
Publicado: (2009)

EXM-86-04: 17/04/1986
por: Malandain, E.
Publicado: (1986)

Toyama H, Li Y, Hatazawa J, Huang G, Kubota K (eds): PET/CT for inflammatory diseases: basic sciences, typical cases, and review: Singapore: Springer Nature Singapore Pte Ltd., 2020, 233 pages, Hardcover, 169.99 €
por: Ito, Kengo
Publicado: (2020)

P04.27. Panax ginseng in randomized controlled trials: a systematic review
por: Shergis, J, et al.
Publicado: (2012)

P04.86. Socio-demographic variations in barriers to participation in an acupuncture clinical trial
por: Tan, T, et al.
Publicado: (2012)

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial
por: Schweitzer, Jana, et al.
Publicado: (2015)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

Predictive chemosensitivity testing.
por: Twentyman, P. R.
Publicado: (1985)

Chemosensitization by lipophilic nitroimidazoles.
por: Twentyman, P. R., et al.
Publicado: (1983)

Chemosensitivity depends on the dependency
por: Short, Ben
Publicado: (2009)

Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer
por: Ichikawa, Wataru, et al.
Publicado: (2016)

Growth Inhibition of Head and Neck Squamous Cell Carcinoma Cells by sgRNA Targeting the Cyclin D1 mRNA Based on TRUE Gene Silencing
por: Iizuka, Satoshi, et al.
Publicado: (2014)

CHEP'04
Publicado: (2004)

CHEP'04
Publicado: (2004)

CHEP'04
Publicado: (2004)

CHEP'04
Publicado: (2004)

P04.82. Yoga for breast cancer: a systematic review of randomized controlled trials
por: Cramer, H, et al.
Publicado: (2012)

SPCR-04 EFFECTS OF BRAIN METASTASES ON NEUROCOGNITIVE FUNCTION: BASELINE RESULTS OF A LONGITUDINAL TRIAL
por: Higazy, Randa, et al.
Publicado: (2022)

Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study
por: Satake, Hironaga, et al.
Publicado: (2018)

Natural history of gastric cancer—a case followed up for eight years: early to advanced gastric cancer
por: Fujisaki, Junko, et al.
Publicado: (2012)

Oxygen dependence for chemosensitization by misonidazole.
por: Roizin-Towle, L., et al.
Publicado: (1986)

Central chemosensitivity, sleep, and wakefulness
por: Nattie, EE, et al.
Publicado: (2001)

DIPG-04. THERAPEUTIC STRATEGY FOR DIFFUSE MIDLINE GLIOMAS. A SINGLE CENTER EXPERIENCE
por: Yamanaka, Takumi, et al.
Publicado: (2020)

P04.14. Acupuncture for carpal tunnel syndrome: a systematic review of randomized controlled trials
por: Shim, H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_08c3t3mhveinv64s5pndd7fuuo